COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021

Jan 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2018-01-19

Reporting Person: Fleming Alison B (Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-19	Common Stock	M	3336	$5.73	Acquired	114755	Direct
2018-01-19	Common Stock	S	3336	$23	Disposed	111419	Direct
2021-01-07	Common Stock	M	16042	$5.73	Acquired	127461	Direct
2021-01-07	Common Stock	S	16042	$22	Disposed	111419	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-19	Stock Option (Right to Purchase)	$5.73	M	3336	Disposed	2025-03-19	Common Stock (3336)	Direct
2021-01-07	Stock Option (Right to Purchase)	$5.73	M	16042	Disposed	2025-03-19	Common Stock (16042)	Direct

Footnotes

F1: The transactions reported in this Form 4 occurring on January 19, 2018 are late due to an administrative error.

F2: The sales occurring on January 19, 2018 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

F3: The sales occurring on January 7, 2021 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.

F4: At the time of exercise, 3,336 shares under the option were exercisable. The option, initially representing a right to purchase a total of 60,378 shares, vested and became exercisable over a four-year period commencing on March 19, 2015. The option vested and became exercisable in equal installments (rounded up to the nearest whole share) on a monthly basis over a four-year period commencing on March 19, 2015, subject to the employee's continued service with the issuer.

F5: The option was fully vested and exercisable as of January 7, 2021.